• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

VOLITIONRX LIMITED

Notes

No. Proposition For Against Abstain
1

DIRECTOR Dr. Phillip Barnes

2

DIRECTOR Dr. Alan Colman

3

DIRECTOR Guy Innes

4

DIRECTOR Kim Nguyen

5

DIRECTOR Cameron Reynolds

6

DIRECTOR Dr. Ethel Rubin

7

DIRECTOR Timothy Still

8

To ratify the selection of Sadler, Gibb & Associates, LLC as the Companys independent registered public accounting firm for the year ending December 31, 2026.

9

To approve, by a non-binding advisory vote, the compensation of the Companys named executive officers.

10

To approve a fourth amendment to the Companys Second Amended and Restated Certificate of Incorporation, as amended, to reduce the number of authorized shares of the Companys common stock, $0.001 par value per share, from 325,000,000 to 150,000,000.

11

To approve the Companys 2026 Stock Incentive Plan.